Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome
Status:
Terminated
Trial end date:
2019-06-10
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of Cannabidiol Oral Solution on
hyperphagia-related behavior in subjects with Prader-Willi Syndrome (PWS). The secondary
objectives of this study are to assess the efficacy, safety and tolerability, impact on
quality of life, and impact on physical activity of Cannabidiol Oral Solution in subjects
with PWS.